8 results
CORRESP
CPHI
China Pharma Holdings Inc.
8 Sep 23
Correspondence with SEC
12:00am
with and may adversely affect our manufacturing operations;
Compliance with China’s new Data Security Law, Measures on Cybersecurity Review, Personal … could materially and adversely affect our liquidity and our ability to fund and expand our business.
Compliance with China’s new Data Security Law
UPLOAD
CPHI
China Pharma Holdings Inc.
25 Jul 23
Letter from SEC
12:00am
, such as those related to
data security or
anti-monopoly concerns, have or may impact the company s
424B5
v9r1ew
16 Dec 21
Prospectus supplement for primary offering
4:05pm
- Prev
- 1
- Next